Diversity Array Technology

Diversity Array Technology (DArT) is a biotechnology company specializing in high-throughput genotyping and molecular marker technologies.

Reviewed by 7wData
Share Email

On this page

Profile

Provides high-throughput genotyping and molecular marker technologies for genetic analysis.

Diversity Array Technology (DArT) is a biotechnology company specializing in high-throughput genotyping and molecular marker technologies. Founded in the early 2000s, the company has developed a reputation for its cost-effective and scalable solutions for genetic analysis. DArT's proprietary technology enables the rapid identification and mapping of genetic markers, which are crucial for applications in agriculture, biodiversity studies, and medical research.

The company's flagship product, DArTseq, is widely used for genome-wide association studies (GWAS) and marker-assisted selection in crop improvement programs. DArT has established a strong presence in the agricultural sector, particularly in emerging markets where affordable genetic tools are in high demand. The company has also expanded its reach into academic and government research institutions, leveraging its technology for biodiversity conservation and population genetics studies.

Financially, DArT has maintained steady growth, supported by recurring revenue from its genotyping services and licensing agreements. Recent strategic moves include partnerships with agricultural biotech firms to integrate DArT's technology into breeding programs for staple crops like wheat, maize, and rice. The company is also exploring opportunities in the burgeoning field of precision medicine, where its genotyping platforms could play a role in personalized healthcare.

However, DArT faces competition from larger players like Illumina, which dominate the high-end sequencing market. Additionally, the company's reliance on agricultural markets exposes it to risks from fluctuating commodity prices and regulatory changes in the biotech sector. Despite these challenges, DArT continues to innovate, with ongoing investments in next-generation sequencing technologies and AI-driven data analysis tools.

Track Diversity Array Technology and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Agricultural biotech firms
  • Academic research institutions
  • Government agencies
  • Seed and crop breeding companies
  • Biodiversity conservation organizations

Strengths and what to watch

Strengths

  • Proprietary DArTseq technology for scalable genotyping
  • Strong presence in emerging agricultural markets
  • Cost-effective solutions compared to competitors

Watch for

  • Competition from larger sequencing companies like Illumina
  • Exposure to agricultural market volatility
  • Regulatory risks in the biotech sector

Key Information

Founded
2001
Headquarters
Canberra, Australian Capital Territory

Frequently Asked Questions

What is Diversity Array Technology (DArT)?

DArT is a biotechnology company specializing in high-throughput genotyping and molecular marker technologies. Founded in the early 2000s, it offers cost-effective solutions for genetic analysis, widely used in agriculture, biodiversity studies, and medical research. Its flagship product, DArTseq, enables rapid genetic marker identification.

How does DArTseq technology work?

DArTseq is a proprietary genotyping platform that identifies and maps genetic markers efficiently. It supports genome-wide association studies (GWAS) and marker-assisted selection in crops. The technology is scalable and cost-effective, making it popular in agricultural biotech and research institutions for genetic analysis.

What are the main applications of DArT technology?

DArT technology is used in crop improvement programs, biodiversity conservation, and medical research. It aids in genetic marker identification, enabling precision breeding in agriculture and population genetics studies. Its cost-effectiveness makes it valuable for emerging markets and academic research.

Who are DArT's primary customers?

DArT serves agricultural biotech firms, academic institutions, government agencies, and biodiversity organizations. Its solutions are particularly popular among seed and crop breeding companies for marker-assisted selection and genetic analysis in staple crops like wheat, maize, and rice.

How does DArT compare to competitors like Illumina?

DArT offers cost-effective genotyping solutions compared to high-end sequencing companies like Illumina. While Illumina dominates the sequencing market, DArT focuses on scalable, affordable technologies for agriculture and emerging markets, though it faces competition in broader biotech applications.

What are the challenges facing DArT?

DArT faces competition from larger biotech firms, exposure to agricultural market volatility, and regulatory risks. Despite these challenges, it continues innovating with next-gen sequencing and AI-driven tools, expanding into precision medicine while maintaining its stronghold in cost-effective genetic analysis.

Sources

  1. www.prnewswire.com — Illumina's financial results and competitive landscape
  2. www.prweb.com — M&A activity in the biotech sector
  3. www.prnewswire.com — Illumina's financial performance and market position
  4. www.businesswire.com — Industry trends in employee benefits and innovation